Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

News

Novavax scores narrower Covid vaccine approval

Digest more
Healthy Returns: Novavax scores narrower Covid vaccine approval after delay
Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's Covid-19 vaccine after more than a month of delay b

Continue reading

 · 2d · on MSN
Infectious Disease Advisor · 1d
FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid
WebMD · 2d
FDA Approves Novavax COVID Vaccine With Restricted Use
STAT
3h
FDA gives Covid vaccine manufacturers instructions for next fall’s shot
The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...
4don MSN
FDA approves Novavax's COVID-19 vaccine with limitations
The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.
1d
New Trump vaccine policy might limit access to your future COVID shots: 10 points
The US Food and Drug Administration changes Covid-19 vaccine approval process. Access to seasonal boosters is restricted for ...
3d
JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News
JPMorgan analyst Eric Joseph reaffirmed an Underweight rating for Novavax Inc. (NASDAQ:NVAX) with a price target of $7. This ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy